Clearside Biomedical Valuation
| CLSDDelisted Stock | USD 0.41 0.16 28.07% |
Clearside Biomedical is overvalued. Clearside Biomedical shows a prevailing Real Value of $0.39 per share. The current price of the firm is $0.41. Our model approximates the value of Clearside Biomedical from analyzing the firm fundamentals such as return on equity of -13.1, and Operating Margin of (35.02) % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Clearside Biomedical's price fluctuation is out of control at this time. Calculation of the real value of Clearside Biomedical is based on 3 months time horizon. Increasing Clearside Biomedical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Clearside stock is determined by what a typical buyer is willing to pay for full or partial control of Clearside Biomedical. Since Clearside Biomedical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Clearside Stock. However, Clearside Biomedical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.41 | Real 0.39 | Hype 0.45 |
The real value of Clearside Stock, also known as its intrinsic value, is the underlying worth of Clearside Biomedical Company, which is reflected in its stock price. It is based on Clearside Biomedical's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Clearside Biomedical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Clearside Biomedical helps investors to forecast how Clearside stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Clearside Biomedical more accurately as focusing exclusively on Clearside Biomedical's fundamentals will not take into account other important factors: About Clearside Biomedical Valuation
The delisted stock valuation mechanism determines Clearside Biomedical's current worth on a weekly basis. Our valuation model uses a comparative analysis of Clearside Biomedical. We calculate exposure to Clearside Biomedical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Clearside Biomedical's related companies.Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. Clearside Biomedical, Inc. was incorporated in 2011 and is headquartered in Alpharetta, Georgia. Clearside Biomedi operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 34 people.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Consideration for investing in Clearside Stock
If you are still planning to invest in Clearside Biomedical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Clearside Biomedical's history and understand the potential risks before investing.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |